Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation

  • Authors:
    • Wei‑Yan Yao
    • Yu‑Fen Zhou
    • Ai‑Hua Qian
    • Yong‑Ping Zhang
    • Min‑Min Qiao
    • Zu‑Kang Zhai
    • Yao‑Zong Yuan
    • Song‑Lin Yang
  • View Affiliations

  • Published online on: October 27, 2014     https://doi.org/10.3892/mmr.2014.2789
  • Pages: 1416-1420
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Severe acute pancreatitis (SAP) accounts for up to 20% of acute pancreatitis (AP) cases. The absence of effective treatment options has resulted in a high rate of morbidity and mortality. Emodin is a major component of the Chinese herb rhubarb, which has been widely used in the treatment of numerous diseases, including inflammation and cancer. There are a limited number of studies however, that have investigated the effectiveness of emodin in the treatment of SAP. The present study used a rat model of SAP, to investigate the effect and molecular mechanisms of emodin treatment. Administration of emodin was identified to significantly attenuate SAP, as determined by serum amylase analysis and histological assessment of edema, vacuolization, inflammation and necrosis (P<0.01). Furthermore, treatment with emodin markedly inhibited nuclear factor (NF)‑κB DNA‑binding activity (P<0.01) and the serum expression levels of tumor necrosis factor‑α, interleukin (IL)‑6 and IL‑1β (P<0.05). This attenuation was associated with decreased malondialdehyde and increased superoxide dismutase levels in the pancreatic tissues and serum (P<0.05). This study indicated that administration of exogenous emodin had therapeutic effects on the severity of SAP. The mechanism may be due to inhibition of NF‑κB activation resulting in an antioxidation response, which can subsequently suppress the expression of cytokines.
View Figures
View References

Related Articles

Journal Cover

February-2015
Volume 11 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yao WY, Zhou YF, Qian AH, Zhang YP, Qiao MM, Zhai ZK, Yuan YZ and Yang SL: Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation. Mol Med Rep 11: 1416-1420, 2015
APA
Yao, W., Zhou, Y., Qian, A., Zhang, Y., Qiao, M., Zhai, Z. ... Yang, S. (2015). Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation. Molecular Medicine Reports, 11, 1416-1420. https://doi.org/10.3892/mmr.2014.2789
MLA
Yao, W., Zhou, Y., Qian, A., Zhang, Y., Qiao, M., Zhai, Z., Yuan, Y., Yang, S."Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation". Molecular Medicine Reports 11.2 (2015): 1416-1420.
Chicago
Yao, W., Zhou, Y., Qian, A., Zhang, Y., Qiao, M., Zhai, Z., Yuan, Y., Yang, S."Emodin has a protective effect in cases of severe acute pancreatitis via inhibition of nuclear factor‑κB activation resulting in antioxidation". Molecular Medicine Reports 11, no. 2 (2015): 1416-1420. https://doi.org/10.3892/mmr.2014.2789